Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Baxter (NYSE:BAX) and the best and worst ...

Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Baxter stock (NYSE: BAX) currently trades at $41 per share, more than 50% lower than the level seen in March 2021, and it can see higher levels over time. BAX stock was trading at around $64 in early ...

Healthcare company Baxter International (NYSE:BAX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 8% year on year to $2.97 billion. Its non-GAAP profit of $0.44 ...

Bax and Bak are activated by BH3-only proteins and inhibited by prosurvival Bcl-2 proteins via direct interactions. Bax and Bak undergo major conformation changes during transition from inactive ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The growth stock trade ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Terry Bax just passed a fundraising milestone: In his 16 years of raising money for local charities, he just hit — and exceeded — the $1 million mark. And, he has declared, now that he’s reached that ...

Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The fourth quarter was defined by ...